Literature DB >> 32852403

De Novo Focal and Segmental Glomerulosclerosis After COVID-19 in a Patient With a Transplanted Kidney From a Donor With a High-risk APOL1 Variant.

Julie Oniszczuk1,2, Anissa Moktefi2,3, Aude Mausoleo1,2, Nicolas Pallet4, Stephanie Malard-Castagnet5, Slim Fourati6,7, Khalil El Karoui1,2, Dil Sahali1,2, Thomas Stehlé1,2, Anna Boueilh1,2, Marie-Christine Verpont8,9, Marie Matignon1,2, David Buob10, Philippe Grimbert1,2, Vincent Audard1,2.   

Abstract

BACKGROUND: There is compelling evidence that renal complications in a native kidney are a major concern in patients infected with severe acute respiratory syndrome coronavirus 2, the causal agent of coronavirus disease 2019 (COVID-19). The spectrum of renal lesions observed on renal grafts in this context remains to be determined.
METHODS: We report the case of a renal transplant recipient with non-severe COVID-19, who subsequently developed nephrotic syndrome associated with acute renal injury.
RESULTS: Renal biopsy demonstrated focal and segmental glomerulosclerosis lesions classified as not otherwise specified histological variant. Genotyping for 2 risk alleles of the apolipoprotein L1 gene demonstrated that the donor was homozygous for the G2/G2 genotype.
CONCLUSIONS: In renal transplant patients receiving kidneys from donors with high-risk apolipoprotein L1 variants, COVID-19 may promote acute glomerular injury in the form of focal and segmental glomerulosclerosis.
Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 32852403     DOI: 10.1097/TP.0000000000003432

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  2 in total

1.  APOL1 risk variants in individuals of African genetic ancestry drive endothelial cell defects that exacerbate sepsis.

Authors:  Junnan Wu; Ziyuan Ma; Archana Raman; Pazit Beckerman; Poonam Dhillon; Dhanunjay Mukhi; Matthew Palmer; Hua Chang Chen; Cassiane Robinson Cohen; Thomas Dunn; John Reilly; Nuala Meyer; Michael Shashaty; Zoltan Arany; György Haskó; Krzysztof Laudanski; Adriana Hung; Katalin Susztak
Journal:  Immunity       Date:  2021-10-12       Impact factor: 43.474

2.  Kidney allograft biopsy findings after COVID-19.

Authors:  Emily Daniel; Miroslav Sekulic; Satoru Kudose; Christine Kubin; Xiaoyi Ye; Katayoon Shayan; Ankita Patel; David J Cohen; Lloyd E Ratner; Dominick Santoriello; M Barry Stokes; Glen S Markowitz; Marcus R Pereira; Vivette D D'Agati; Ibrahim Batal
Journal:  Am J Transplant       Date:  2021-09-03       Impact factor: 9.369

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.